BioNTech SE - ADR vs Essex Property Trust, Inc. — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Essex Property Trust, Inc. trades at $282.11 (market cap $18.15B). The key difference: BioNTech SE - ADR is the larger of the two by market cap, and Essex Property Trust, Inc. pays a 3.93% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | ESS | |
|---|---|---|
Market Cap | $23.31B | $18.15B |
Sector | Health | Real Estate |
52-Week High | $119.34 | $298.33 |
52-Week Low | $83.89 | $239.61 |
Enterprise Value | $6.60B | $24.75B |
Dividend Yield | — | 3.93% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Essex Property Trust owns a portfolio of 253 apartment communities with over 62,000 units and is developing three additional properties with 571 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
Read more on ESS →